Table 1.

Acute pharmacological modulation of KA elicited gamma oscillations.

	n	Total Gamma Power	Peak Power	Peak Frequency
Ketamine (100 µM)	11	57.9 ± 17.1**	98.9 ± 24.2*	−12.1 ± 1.4**
AP-5 (50 µM)	17	50.6 ± 19.8**	113 ± 26.3**	−1.1 ± 2.3
MK-801 (10 µM)	13	41.0 ± 14.7*	171.2 ± 39.0*	1.1 ± 4.8
Ro 25-6981 (1 µM)	5	46.8 ± 11.0*	114.3 ± 36.2*	2.1 ± 4.5
PEAQX (500 nM)	6	−4.0 ± 17.7	21.3 ± 28.1	6.3 ± 3.9
PPPA (500 nM)	5	−9.4 ± 12.8	−5.3 ± 25.4	−1.0 ± 2.7
Quinipirole (30 µM)	6	−13.0 ± 16.1	−8.1 ± 25.6	−1.6 ± 3.2
α-methyl-5-HT (25 µM)	6	−6.4 ± 22.8	5.3 ± 26.9	3.0 ± 3.1
Ketamine (100 µM) + Risperidone (1 µM)	5	58.0 ± 36.3*	99.3 ± 42.2	−12.4 ± 0.8**

Data is the mean ± SEM.

^*value is significantly (p < 0.05) different from control.

^**value is significantly (p < 0.01) different from control